Přemysl Poňka

2.5k total citations
64 papers, 2.2k citations indexed

About

Přemysl Poňka is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Přemysl Poňka has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Hematology and 18 papers in Genetics. Recurrent topics in Přemysl Poňka's work include Porphyrin Metabolism and Disorders (17 papers), Hemoglobinopathies and Related Disorders (17 papers) and Iron Metabolism and Disorders (16 papers). Přemysl Poňka is often cited by papers focused on Porphyrin Metabolism and Disorders (17 papers), Hemoglobinopathies and Related Disorders (17 papers) and Iron Metabolism and Disorders (16 papers). Přemysl Poňka collaborates with scholars based in Czechia, Canada and Australia. Přemysl Poňka's co-authors include J Neuwirt, J Borová, Herbert M. Schulman, Des R. Richardson, Ania Wilczynska, E Nečas, Erica Baker, Ota Fuchs, Vladimír Geršl and Martin Štěrba and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

Přemysl Poňka

64 papers receiving 2.2k citations

Peers

Countries citing papers authored by Přemysl Poňka

Since Specialization

Citations

This map shows the geographic impact of Přemysl Poňka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Přemysl Poňka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Přemysl Poňka more than expected).

Fields of papers citing papers by Přemysl Poňka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Přemysl Poňka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Přemysl Poňka. The network helps show where Přemysl Poňka may publish in the future.

Co-authorship network of co-authors of Přemysl Poňka

This figure shows the co-authorship network connecting the top 25 collaborators of Přemysl Poňka. A scholar is included among the top collaborators of Přemysl Poňka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Přemysl Poňka. Přemysl Poňka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyridoxal Isonicotinoyl Hydrazone (PIH) and its Analogs as Protectants Against Anthracycline-Induced Cardiotoxicity 2008 ·Hemoglobin ·Tomáš Šimůnek, Martin Štěrba, Olga Popelová, Helena Mertlíková‐Kaiserová, (unknown), Michaela Adamcová, Y Mazurová, Přemysl Poňka, Vladimír Geršl	7
2	Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH) 2007 ·Toxicology ·Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Y Mazurová, (unknown), Michaela Adamcová, (unknown), Helena Mertlíková‐Kaiserová, Vladimír Palička, Přemysl Poňka, Vladimír Geršl	29
3	HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study 2006 ·Journal of Chromatography B ·Petra Kovařı́ková, Jiřı́ Klimeš, Martin Štěrba, Olga Popelová, Vladimír Geršl, Přemysl Poňka	14
4	SIH—a novel lipophilic iron chelator—protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death 2005 ·Journal of Molecular and Cellular Cardiology ·Tomáš Šimůnek, Christa Boer, R. Arthur Bouwman, (unknown), Amanda Versteilen, Martin Štěrba, Vladimír Geršl, Radim Hrdina, Přemysl Poňka, (unknown)	83
5	Mobilization of iron from cells by hydroxyquinoline-based chelators 2005 ·Biochemical Pharmacology ·(unknown), Joan L. Buss, Brent R. Stranix, Jik Chin, Přemysl Poňka	10
6	Development of high‐performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study 2005 ·Journal of Separation Science ·Petra Kovařı́ková, Jiřı́ Klimeš, Martin Štěrba, Olga Popelová, (unknown), Vladimír Geršl, Přemysl Poňka	29
7	Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits 2004 ·Pharmacological Research ·Tomáš Šimůnek, (unknown), (unknown), Martin Štěrba, Y Mazurová, Michaela Adamcová, Radomír Hrdina, Vladimír Geršl, Přemysl Poňka	40
8	Cardiac Troponins Following Repeated Administration of an Iron Chelator – Salicylaldehyd Isonicotinoyl Hydrazone (SIH) – in Rabbits 2003 ·Acta Medica (Hradec Kralove Czech Republic) ·Michaela Adamcová, Martin Štěrba, (unknown), Tomáš Šimůnek, Radomír Hrdina, Vladimír Geršl, Přemysl Poňka	4
9	A Study of Potential Toxic Effects After Repeated 10-Week Administration of a New Iron Chelator – Salicylaldehyde Isonicotinoyl Hydrazone (SIH) to Rabbits 2003 ·Acta Medica (Hradec Kralove Czech Republic) ·(unknown), Tomáš Šimůnek, (unknown), (unknown), Martin Štěrba, Radomír Hrdina, Vladimír Geršl, Michaela Adamcová, Přemysl Poňka	18
10	Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism 1998 ·American Journal of Hematology ·Des R. Richardson, Přemysl Poňka	1
11	Biliary Iron Excretion in Rats Following Treatment With Analogs of Pyridoxal Isonicotinoyl Hydrazone 1998 ·Blood ·K. Bláha, M. Cikrt, (unknown), (unknown), Přemysl Poňka	27
12	Pyridoxal isonicotinoyl hydrazone and its analogs: Potential orally effective iron-chelating agents for the treatment of iron overload disease 1998 ·Journal of Laboratory and Clinical Medicine ·Des R. Richardson, Přemysl Poňka	115
13	Selective Inhibition of IκBα Phosphorylation and HIV-1 LTR-Directed Gene Expression by Novel Antioxidant Compounds 1997 ·Virology ·Raymond Lee, Pierre Beauparlant, Howard L. Elford, Přemysl Poňka, John Hiscott	48
14	Prevention of Postasphyxia Electroretinal Dysfunction with a Pyridoxal Hydrazone 1997 ·Free Radical Biology and Medicine ·Mousumi Bhattacharya, Přemysl Poňka, Pierre Hardy, (unknown), Daya R. Varma, Pierre Lachapelle, Sylvain Chemtob	22
15	Regulation of Mammalian Iron Metabolism: Current State and Need for Further Knowledge 1997 ·Critical Reviews in Clinical Laboratory Sciences ·Hans Goldenberg, Přemysl Poňka	7
16	IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma 1996 ·The Journal of Immunology ·(unknown), Frederick P. Nestel, (unknown), Přemysl Poňka, Wayne S. Lapp	45
17	In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs 1995 ·Redox Report ·Herbert M. Schulman, Marcelo Hermes‐Lima, (unknown), Přemysl Poňka	24
18	Distinct Features of Iron Metabolism in Erythroid Cells: Implications for Heme Synthesis Regulation 1994 ·Advances in experimental medicine and biology ·Přemysl Poňka, Herbert M. Schulman	5
19	Control of Iron Delivery to Haemoglobin in Erythroid Cells 1977 ·Novartis Foundation symposium ·Přemysl Poňka, J Neuwirt, J Borová, Ota Fuchs	13
20	Problems of reduced heme synthesis in reticulocytes with impaired globin synthesis 1969 ·Annals of Hematology ·J Neuwirt, Přemysl Poňka, J Borová, JF Prchal	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact